<DOC>
	<DOCNO>NCT01779518</DOCNO>
	<brief_summary>This single arm , open-label study open specific clinical site request investigator treatment individual subject treatment option . Subjects treat 24 week sofosbuvir ( 400mg QD ) RBV ; pegylated interferon may add discretion investigator .</brief_summary>
	<brief_title>Expanded Access Program Sofosbuvir With Ribavirin With Without Pegylated Interferon Aggressive Post-transplant Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Molecular Mechanisms Pharmacological Action</mesh_term>
	<criteria>Age &gt; = 18 year Previously undergone orthotopic liver transplant ( OLT ) least 2 month prior plan start dose Aggressive Hepatitis C infection ( include fibrosing cholestatic hepatitis C ) Life expectancy &lt; 12 month HCV leave untreated History clinically significant drug allergy nucleoside/nucleotide analogs Participation clinical study investigational drug biologic within 1 month prior anticipate dose administration , unless information available determine safety drugdrug interaction risk subject Unable unwilling follow contraception requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>HCV</keyword>
	<keyword>Sustained Virologic Response</keyword>
	<keyword>Direct Acting Antiviral</keyword>
	<keyword>GS-7977</keyword>
	<keyword>Pegylated interferon</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Open Label</keyword>
	<keyword>Sofosbuvir</keyword>
	<keyword>Liver transplant</keyword>
	<keyword>Hepatitis</keyword>
	<keyword>Hepatitis , Chronic</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Hepatitis C , Chronic</keyword>
	<keyword>Liver Diseases</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Hepatitis , Viral , Human</keyword>
	<keyword>Virus Diseases</keyword>
	<keyword>Enterovirus Infections</keyword>
	<keyword>Picornaviridae Infections</keyword>
	<keyword>RNA Virus Infections</keyword>
	<keyword>Flaviviridae Infections</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Anti-Infective Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Antimetabolites</keyword>
	<keyword>Molecular Mechanisms Pharmacological Action</keyword>
</DOC>